Samenvatting

Summary Q8 Biomedical Evidence

2 keer verkocht

Instelling
Radboud Universiteit Nijmegen (RU)

Deze samenvatting omvat alle nodige leerstof nodig voor het Q8 tentamen; infectious diseases and global health, alzheimer's disease, renal disorders, nanomedicine en tot slot bioinformatics and big data. De samenvatting is gebaseerd op de lectures en ZSO's.

[Meer zien]

Voorbeeld 4 van de 62 pagina's

Bekijk voorbeeld

Geupload op 22 juni 2023
Aantal pagina's 62
Geschreven in 2022/2023
Type Samenvatting

renals disorders
nanomedicine
bioinformatics
big data
kwartaal 8
biomedische wetenschappen
biomedical sciences
infectious diseases and global health
alzheimers disease

Volgen

stellav19 Lid sinds 4 jaar 65 documenten verkocht

€9,99

In winkelwagen

Opslaan

100% tevredenheidsgarantie
Direct beschikbaar na je betaling
Lees online óf als PDF
Geen vaste maandelijkse kosten

INFECTIOUS DISEASES AND GLOBAL HEALTH
HIV AND AIDS INTRODUCTION

Short summary viral replication of HIV: HIV fuses with the surface of
the host cell. The viral capsid enters the cell, disintegrates and the HIV
protein called reverse transcriptase transcribes the viral RNA into DNA.
The viral DNA is transported across the nucleus, where the HIV protein
integrase integrates the HIV DNA into the host’s DNA. The host’s
normal transcription machinery transcribes HIV DNA into multiple
copies of new HIV RNA. Some of this RNA becomes the genome of a
new virus, while the cell uses other copies of the RNA to make new
HIV proteins. The new viral RNA and HIV proteins move to the surface
of the cell, where a new, immature HIV forms. Finally, the virus is
released from the cell, and the HIV protein called protease cleaves
newly synthesized polyproteins to create a mature infectious virus.

HIV and DC4 cells

- HIV infects and destroys CD4 cells
- Only 1% of these cells are present in the blood, majority in lymph nodes (mostly gut)
- Loss of CD4+ memory T-cells decreases ‘cellular immunity’ and predisposes to certain infection and
malignancies
- CD4 also on other cells: megakaryocytes  HIV can cause low blood platelets, glial cells in the brain 
HIV can lead to dementia
- ‘viral setpoint’ and CD4-cell loss: when viral load is low or going down, CD4 counts will be higher or
going up

CLINICAL PRESENTATION

Primary HIV

- Usually 2-4 weeks after infection
- Flu-like syndrome: fever, lymphadenopathy, pharyngitis, rash etc; sometimes severe:
meningoencephalitis
- Laboratory results
o Mononucleosis (atypical lymphocytes)
o High plasma HIV-RNA (106 copies/ml)
o Incomplete antibody response
o Temporary drop in CD4

If not treated, HIV (human immunodeficiency virus) can lead to AIDS (acquired immunodeficiency disease) =
an HIV infection with either a CD4+ T cell count below 200 cells per µL or the occurrence of specific diseases
associated with HIV infection (opportunistic infections):

- Fungi; pneumocystis, cryptococcus, candida, histoplasmosis
- Parasites: toxoplasmosis (cerebral), cryptosporidium, leishmania, microspore.
- Bacteria: mycobacterium, tuberculosis, atypical mycobacteria, salmonella
- Viruses: HSV, CMV retinitis (blindness), VZV, JC
- Malignancies: Kaposi sarcoma (HHV-8), lymphoma (EBV), others

Besides infections and AIDS:

1

, - Cardiovascular disease
- ‘normal’ malignancies
- Allergy and autoimmune disease more rapid ‘aging’ of many organ systems (liver, kidney, lungs, brain,
bone, …)
- Patients who live longer: chronic disease

Summary clinical course, natural course of disease after infection is variable:

- Acute HIV (viral syndrome)
- Many patients with asymptomatic infection
- (opportunistic) infection & malignancies (AIDS)
- ‘chronic HIV’ – organ dysfunction

HIV TREATMENT

Anti-retroviral treatment (ART)

- Entry blockers
- Reverse transcriptase inhibitors
- Integrase inhibitors
- Protease inhibitors

ART given for multiple reasons (symptom reduction, transmission prevention, slowing down of chronic HIV,…)
and is extremely effective. However, there can be some side effects such as Steven-Johnson syndrome (SJS) and
mitochondrial toxicity:

- Nucleoside RT inhibitors (NRTIs)
- Phosphorylation intracellularly
- Also inhibition of gamma-polymerase (replication mtDNA)
- Affects respiratory chain: less ATP, effect on fatty acid metabolism (accumulation triglycerides), less
DNA synthesis
- Time and concentration dependent (esp. older drugs)
- Lethal if unrecognised
- Not seen with newer drugs!

Monitoring HIV treatment: plasma HIV RNA (viral load) to assess level of HIV viremia and CD4+ T lymphocyte
cell count (or CD4 count) to assess immune function.

HIV indicator condition with undiagnosed HIV = STDs, malignant lymphoma, anal cancer, Herpes Zoster,
Hepatitis B or C, …

HIV IN THE NETHERLANDS

- Becoming a chronic disease
- Higher CD4 at time of diagnosis
- Very effective treatment, few deaths
- More non-communicable co-morbidity
- PreP: fewer new infections

Many other parts of the world: too little progress in control, large gaps in ‘cascade of care’, AIDS/opportunistic
infections/high mortality, stigma/social issues/dwindling investments etc

DISEASE HETEROGENEITY: IDENTIFYING CAUSES ALONG THE PATIENT JOURNEY

2

,While disease may have established typical presentation, in daily practice presentation may be (very)
heterogenous ; at different phases along patient trajectory, for different aspects of disease presentation: onset,
symptoms, natural course, treatment response.

- Heterogeneity caused by: disease characteristics itself, patient characteristics, care characteristics,
wider context

Relevance of diagnosis: a diagnosis informs about prognosis (natural course), e.g. life expectancy, future health,
future functioning and well-being, …  a diagnosis informs how treatment will change the natural course. (also
important for epidemic conditions)

Diseases show heterogeneity in…

- Onset; why one person gets a disease/diagnosis and why another doesn’t
- Symptoms
- Natural progression
- Treatment response and outcomes
 Depends: personal characteristics, care characteristics
- E.g. Dementia
o Significant cognitive decline from previous level of performance in one or more domains
o Interference with everyday activities
o Stages: mild cognitive impairment (MCI), dementia
- E.g. HIV associated neurocognitive disorders (HAND)
o The presence of neurocognitive deficits in HIV-infected individuals without alternative
explanation other than HIV infection
o Stages: asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND),
HIV-associated dementia (HAD)

How to study heterogeneity? Identify where the heterogeneity occurs;

Conclusion

- While disease may have established typical presentation, in daily practice disease presentation may be
(very) heterogenous
o At different phases along patient trajectory
o For different aspects of disease presentation: onset, symptoms, natural course, treatment
response
- Heterogeneity can be cause by
o Disease characteristics itself
o Patients characteristics
o Care characteristics

3

, o Wider contexts

VARIATION IN QUALITY OF PROFESSIONAL CARE: HIV AS AN EXAMPLE

Central question in quality of care research: how can we achieve that, in daily practice, patients receive the
best available prevention, diagnosis and treatment of their health problems?

- What is appropriate care
- Is appropriate care provided
- What are the determinants
- How to improve care for patients, what are the conditions for sustainable improvement?

Improvement interventions are morelikely to be successful if determinants that influence (help/hinder)
appropriate care inform the choice of intervention.

In conclusion

- Large variation in quality of care between organizations and professionals
- This variation can be explained by many determinants
- To successfully influence variation, we need tailored interventions

HIV – VIROLOGY AND ANTIRETROVIRAL THERAPY

RETROVIRUSES – A HISTORICAL PERSPECTIVE

Transformation of cells by a virus was associated with integration of viral DNA in the host genome > to great
surprise, these tumour viruses were found to have RNA genomes, how could viruses transform cells? 
Reverse transcriptase discovery:

- Enzyme that counters the central dogma (DNA > RNA > protein)  reverses the flow of genetic
information
- Temin: RNA viruses must convert their genetic material from RNA to DNA that is subsequently
integrated in the host DNA
- Baltimore: enzyme that converts RNA to DNA must be carried along in the viral particle, as no such
enzymes exist in eukaryotic host cells

HIV – STRUCTURE AND CLASSIFICATION

Baltimore classification

- Class VI: ssRNA (+/) retrovirus: make ssRNA (+) genome by transcription of (-) strand of dsDNA

- Single stranded, positive sense (+) RNA genomes
- Cytoplasmic (+) strand RNA viruses directly translate the incoming viral RNA
- Retroviruses use the incoming (+) strand RNA to create a DNA intermediate

4

Dit zijn jouw voordelen als je samenvattingen koopt bij Stuvia:

Bewezen kwaliteit door reviews

Studenten hebben al meer dan 850.000 samenvattingen beoordeeld. Zo weet jij zeker dat je de beste keuze maakt!

In een paar klikken geregeld

Geen gedoe — betaal gewoon eenmalig met iDeal, creditcard of je Stuvia-tegoed en je bent klaar. Geen abonnement nodig.

Direct to-the-point

Studenten maken samenvattingen voor studenten. Dat betekent: actuele inhoud waar jij écht wat aan hebt. Geen overbodige details!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper stellav19. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor €9,99. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 66184 samenvattingen verkocht

Opgericht in 2010, al 15 jaar dé plek om samenvattingen te kopen

Begin nu gratis

Samenvatting

Summary Q8 Biomedical Evidence

Document informatie

Onderwerpen

Geschreven voor

Verkoper

Ontvangen beoordelingen

Voorbeeld van de inhoud